Arabia Insurance Cooperative Company (8160.SR)
SAR 12.98
(0.46%)
SAR 12.98
(0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 79.88 Million | 131.34 Million | -29.7 Million | -25.86 Million | -39.95 Million | 4.57 Million |
| Net Income | 66.29 Million | 9.33 Million | -5.51 Million | 7.07 Million | -42.31 Million | 3.41 Million |
| Depreciation & Amortization | 5.17 Million | 4.92 Million | 4.77 Million | 4.17 Million | 3.92 Million | 1.56 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.54 Million | 116.32 Million | -19.2 Million | -27.81 Million | -17.83 Million | -13.41 Million |
| Other non-cash items | 6.86 Million | 763.18 Thousand | -9.76 Million | -9.29 Million | 16.26 Million | 1.15 Million |
| Investing Cash Flow | -348.88 Million | -135.98 Million | -31.94 Million | 110.76 Million | 16.31 Million | -63.84 Million |
| Investments in PPE | -5.12 Million | -5.73 Million | -3.43 Million | -2.09 Million | -2.14 Million | -3.1 Million |
| Acquisitions | 343.76 Million | - | 28.51 Million | 3000.00 | -18.45 Million | - |
| Investment purchases | -352.61 Million | -130.24 Million | -34.81 Million | -112.85 Million | -18.96 Million | -96.57 Million |
| Sales/Maturities of investments | 21.85 Million | - | 6.3 Million | 112.85 Million | 37.41 Million | 35.83 Million |
| Other Investing Activities | -343.76 Million | -1.00 | -28.51 Million | 112.85 Million | 18.45 Million | -63.84 Million |
| Financing Cash Flow | 247.6 Million | -1.58 Million | -2.32 Million | -2.16 Million | -480.56 Thousand | - |
| Debt repayment | -2.48 Million | -1.58 Million | -2.32 Million | -2.16 Million | -480.56 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 250.09 Million | - | - | - | - | - |
| Other Financing Activities | 250.09 Million | -1.58 Million | -2.32 Million | -2.16 Million | -480.56 Thousand | - |
| Accounts receivables | - | -83.83 Million | -214.8 Thousand | -22.41 Million | -10.87 Million | -18.11 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.54 Million | 200.16 Million | -18.98 Million | -5.39 Million | -6.96 Million | -8.25 Million |
| Cash at beginning of period | 79.11 Million | 85.34 Million | 149.32 Million | 66.59 Million | 90.71 Million | 149.99 Million |
| Cash at end of period | 57.71 Million | 79.11 Million | 85.34 Million | 149.32 Million | 66.59 Million | 90.71 Million |
| Capital Expenditure | -5.12 Million | -5.73 Million | -3.43 Million | -2.09 Million | -2.14 Million | -3.1 Million |
| Effect of forex changes on cash | -13 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -21.39 Million | -6.22 Million | -63.98 Million | 82.73 Million | -24.12 Million | -59.27 Million |
| Free Cash Flow | 74.75 Million | 125.6 Million | -33.14 Million | -27.95 Million | -42.09 Million | 1.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 13.22 Million | 8.7 Million | 72.12 Million | 11.65 Million | 22.22 Million | 19.95 Million |
| Depreciation & Amortization | 1.65 Million | 1.75 Million | 5.17 Million | 1.61 Million | 1.29 Million | 1.15 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -18.31 Million | -9.75 Million | 1.15 Million | -42.93 Million | 50.79 Million | -9.39 Million |
| Other non-cash items | -5.2 Million | 6.03 Million | 11.78 Million | 9.02 Million | 3.67 Million | -2.08 Million |
| Investing Cash Flow | 69.3 Million | 41.75 Million | -335.88 Million | -80.67 Million | -57.73 Million | 8.62 Million |
| Investments in PPE | -297.98 Thousand | -108.37 Thousand | -5.12 Million | -1.84 Million | -561.83 Thousand | -515.27 Thousand |
| Acquisitions | - | - | 343.76 Million | 78.82 Million | 57.17 Million | -22.13 Million |
| Investment purchases | - | - | -352.61 Million | -79.58 Million | -57.46 Million | 1.32 Million |
| Sales/Maturities of investments | 69.59 Million | 41.86 Million | 21.85 Million | 758.08 Thousand | 284.1 Thousand | 20.81 Million |
| Other Investing Activities | 69.79 Million | 35.5 Million | -343.76 Million | -78.82 Million | -57.17 Million | 9.13 Million |
| Financing Cash Flow | -1.37 Million | -75.14 Thousand | 247.6 Million | -491.49 Thousand | -1.58 Million | -53.78 Thousand |
| Debt repayment | -1.37 Million | -75.14 Thousand | -2.48 Million | -491.49 Thousand | -1.58 Million | -53.78 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 250.09 Million | - | 6.00 | -4.00 |
| Other Financing Activities | -1.37 Million | - | 250.09 Million | -491.49 Thousand | 6.00 | -4.00 |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -18.3 Million | -8.84 Million | 1.54 Million | -42.68 Million | 50.79 Million | -9.39 Million |
| Cash at beginning of period | 155.63 Million | 110.71 Million | 119.11 Million | 215.75 Million | 144.07 Million | 125.87 Million |
| Cash at end of period | 211.61 Million | 155.63 Million | 110.71 Million | 110.71 Million | 162.75 Million | 144.07 Million |
| Capital Expenditure | -297.98 Thousand | -108.37 Thousand | -5.12 Million | -1.84 Million | -561.83 Thousand | -515.27 Thousand |
| Effect of forex changes on cash | - | - | -13 Million | - | - | -1.00 |
| Net cash flow / Change in cash | 55.97 Million | 44.91 Million | -8.39 Million | -105.03 Million | 18.67 Million | 18.2 Million |
| Free Cash Flow | -12.25 Million | 3.12 Million | 74.75 Million | -25.71 Million | 77.43 Million | 9.11 Million |
3539
GAGAN
KNO
AARTIPHARM
ALB
ATH